Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
GP00167 | MSTRG.34636.7 gRNA1-gRNA2 KO plasmid | MSTRG.34636.7 | $850 | |||
KO00588 | MSTRG.34636.7 Knockout cell line(HCT 116) | Human | MSTRG.34636.7 | 1:2~1:4 | Negative | Online Inquiry |
MSTRG.34636.7 Gene Knockout Cell Lines are specialized mammalian cell lines engineered to have a targeted knockout of the MSTRG.34636.7 gene, utilizing CRISPR-Cas9 technology for precise editing. These cell lines serve as a critical tool for exploring gene function and elucidating the biological pathways implicated in various diseases. Their creation involves the introduction of a double-stranded break at specific genomic loci, which subsequently triggers cellular repair mechanisms that can lead to the integration of a non-functional allele, effectively silencing the target gene.
The key functions of these knockout cell lines lie in their utility for gene function studies, drug screening, and cellular behavior analysis under modified genetic conditions. By eliminating the MSTRG.34636.7 gene, researchers can observe the resulting phenotypic changes, enabling them to investigate the gene's role in cellular processes such as proliferation, differentiation, and response to pharmacological agents. This approach empowers scientists to develop more accurate disease models and identify potential therapeutic targets.
In the landscape of genetic engineering and functional genomics, MSTRG.34636.7 Gene Knockout Cell Lines stand out for their high specificity and efficiency. Unlike alternative methods that may cause off-target effects or involve more labor-intensive protocols, our product simplifies the process of gene targeting, ensuring reproducibility and reliability in experimental outcomes. Moreover, they are pivotal for advancing our understanding of gene interactions in various disease contexts, from cancer to metabolic disorders, making them invaluable in both academic and clinical research settings.
For researchers and clinicians, the value of MSTRG.34636.7 Gene Knockout Cell Lines cannot be overstated. They allow for the generation of robust datasets that can accelerate the discovery of novel treatments and inform therapeutic strategies. Furthermore, our company's commitment to excellence in biotechnological advancements ensures that we provide high-quality, ready-to-use cellular models, backed by extensive scientific expertise and support. As leaders in the field, we are dedicated to empowering researchers with innovative solutions that drive scientific progress.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.